LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

266.63 -2.6

Rezumat

Modificarea prețului

24h

Curent

Minim

265.69

Maxim

273.36

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

40.81

105.69

EPS

1.96

Randament dividend

0.31

Marjă de profit

17.406

Angajați

10,600

EBITDA

17M

215M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+26.94% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.31%

2.37%

Data viitoare de dividende

19 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

51M

20B

Deschiderea anterioară

269.23

Închiderea anterioară

266.63

Sentimentul știrilor

By Acuity

50%

50%

171 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 nov. 2025, 21:34 UTC

Câștiguri

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 nov. 2025, 23:45 UTC

Market Talk

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 nov. 2025, 23:42 UTC

Achiziții, Fuziuni, Preluări

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 nov. 2025, 23:41 UTC

Market Talk

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 nov. 2025, 23:24 UTC

Câștiguri

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 nov. 2025, 23:24 UTC

Câștiguri

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 nov. 2025, 23:23 UTC

Câștiguri

JBS NV 3Q EPS 52c >JBS

13 nov. 2025, 23:23 UTC

Câștiguri

JBS NV 3Q Sales $22.6B >JBS

13 nov. 2025, 23:04 UTC

Market Talk

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 nov. 2025, 22:02 UTC

Câștiguri

Nu Holdings 3Q Net $783M >NU

13 nov. 2025, 22:01 UTC

Câștiguri

Nu Holdings 3Q Rev $4.2B >NU

13 nov. 2025, 21:51 UTC

Achiziții, Fuziuni, Preluări

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 nov. 2025, 21:50 UTC

Câștiguri

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 nov. 2025, 21:45 UTC

Achiziții, Fuziuni, Preluări

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 nov. 2025, 21:41 UTC

Achiziții, Fuziuni, Preluări

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 nov. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 nov. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 nov. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 nov. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 nov. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 nov. 2025, 21:33 UTC

Market Talk

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 nov. 2025, 21:33 UTC

Câștiguri

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 nov. 2025, 21:31 UTC

Câștiguri

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 nov. 2025, 21:25 UTC

Câștiguri

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 nov. 2025, 21:25 UTC

Câștiguri

Figure Tech Solutions 3Q EPS 34c >FIGR

13 nov. 2025, 21:23 UTC

Câștiguri

Intchains Group 3Q Rev $1.3M >ICG

13 nov. 2025, 21:03 UTC

Câștiguri

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 nov. 2025, 21:02 UTC

Câștiguri

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 nov. 2025, 21:01 UTC

Câștiguri

Applied Materials 4Q Rev $6.8B >AMAT

13 nov. 2025, 21:01 UTC

Câștiguri

Applied Materials 4Q Gross Margin 48.0% >AMAT

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

26.94% sus

Prognoză pe 12 luni

Medie 347.63 USD  26.94%

Maxim 375 USD

Minim 311 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

9

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

171 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat